摘要
背景:轻度认知障碍(MCI)是正常认知与痴呆之间的过渡状态。 目的:本研究的目的是在包括471个健忘MCI(a-MCI),693个健忘MCI多结构域的MCI类型的大型医院队列中研究血管危险因素,血管疾病,脑血管疾病和脑萎缩的作用(a-MCImd),322个单非存储器MCI(snm-MCI)和202个非遗忘MCI多域(na-MCImd)。为了比较,还评估了1005名神经和认知健康的受试者。 方法:评估几种血管危险因素和血管疾病。所有参与者接受神经学,神经心理学和行为评估以及颈动脉超声和标准脑MRI。使用NCI群组和a-MCI类型作为参考类别的MCI群组的多项式逻辑回归模型被用来评估评估变量对四种MCI类型之一的估计概率的影响。 结果:本研究表明,脑血管疾病对非记忆性MCI类型和α-MCImd类型的风险有很大贡献,并且脑萎缩存在于所有MCI类型中,并且在多种结构域类型中尤其如此,在na-MCI类型中更大。 结论:强制老年人改善脑血管病的检测和控制。由于MCI和痴呆的发病率预计会随着预期寿命的延长而上升,因此更好的脑血管疾病管理确实可以预防或延迟MCI的发病,或者可以延缓MCI向痴呆的进展
关键词: 轻度认知功能障碍类型,血管危险因素,血管疾病,丘疹,非腔隙性梗死,白质高信号,脑萎缩
Current Alzheimer Research
Title:Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital-based Cohort of Mild Cognitive Impairment Types
Volume: 15 Issue: 7
关键词: 轻度认知功能障碍类型,血管危险因素,血管疾病,丘疹,非腔隙性梗死,白质高信号,脑萎缩
摘要: Background: Mild Cognitive Impairment (MCI) is a transitional state between normal cognition and dementia.
Objective: The aim of this study is to investigate the role of vascular risk factors, vascular diseases, cerebrovascular disease and brain atrophy in a large hospital-based cohort of MCI types including 471 amnestic MCI (a-MCI), 693 amnestic MCI multiple domain (a-MCImd), 322 single non-memory MCI (snm-MCI), and 202 non amnestic MCI multiple domain (na-MCImd). For comparison, 1,005 neurologically and cognitively healthy subjects were also evaluated.
Method: Several vascular risk factors and vascular diseases were assessed. All participants underwent neurological, neuropsychological and behavioural assessments as well as carotid ultrasonography and standard brain MRI. Multinomial logistic regression models on the MCI cohort with the NCH group and a-MCI type as reference categories were used to assess the effects of the variables evaluated on the estimated probability of one of the four MCI types.
Results: This study demonstrates that cerebrovascular disease contributes substantially to the risk of non-memory MCI types and a-MCImd type, and that brain atrophy is present in all MCI types and is greater in multiple domain types particularly in the na-MCI type.
Conclusion: Improving detection and control of cerebrovascular disease in aging individuals should be mandatory. Since the incidence of MCI and dementia will be expected to rise because of the progressive life expectancy, a better management of cerebrovascular disease could indeed prevent or delay the onset of MCI, or could delay progression of MCI to dementia.
Export Options
About this article
Cite this article as:
Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital-based Cohort of Mild Cognitive Impairment Types, Current Alzheimer Research 2018; 15 (7) . https://dx.doi.org/10.2174/1567205015666180119110712
DOI https://dx.doi.org/10.2174/1567205015666180119110712 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cardiac Nuclear Imaging: Current Status and Future Directions
Current Medical Imaging Efficacy and Cardiovascular Safety of Insulins
Current Drug Safety Role of Platelets in Angiogenesis in Health and Disease
Current Angiogenesis (Discontinued) The Roles of Corticotropin Releasing Factor (CRF) in Responses to Emotional Stress: Is CRF Release a Cause or Result of Fear/Anxiety?
CNS & Neurological Disorders - Drug Targets Formaldehyde as a trigger for protein aggregation and potential target for mitigation of age-related, progressive cognitive impairment
Current Topics in Medicinal Chemistry Left Ventricular 2-[<sup>18</sup>F]-Fluoro-2-Deoxy-D-Glucose Uptake Using Modified Oral Glucose Loading Protocol With Pre-Medicated Niacin On Positron Emission Tomography/Computed Tomography - A Preliminary Study
Current Molecular Imaging (Discontinued) The Neonatal Kidney: Implications for Drug Metabolism and Elimination
Current Drug Metabolism Biologic Agents in the Treatment of Psoriasis
Recent Patents on Inflammation & Allergy Drug Discovery Biological Nitration of Arachidonic Acid
Current Vascular Pharmacology Oxidative Stress Correlates (OSC) in Diabetes Mellitus Patients
Current Diabetes Reviews The Prevalence of the Classical and Non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients
CNS & Neurological Disorders - Drug Targets Fat Tissue Distribution Changes in HIV-Infected Patients Treated with Lopinavir/Ritonavir. Results of the MONARK Trial
Current HIV Research Nampt/Visfatin/PBEF: A Functionally Multi-faceted Protein with a Pivotal Role in Malignant Tumors
Current Pharmaceutical Design Medical Management of the Diabetic Patient with Coronary Artery Disease
Current Pharmaceutical Design Placental Drug Disposition and Its Clinical Implications
Current Drug Metabolism Cerebral Inflow and Outflow Discrepancies in Severe Sudden Sensorineural Hearing Loss
Current Neurovascular Research Best Practice for Atrial Fibrillation Patient Education
Current Pharmaceutical Design Review of Trans-Atlantic Cardiovascular Best Medical Therapy Guidelines – Recommendations for Asymptomatic Carotid Atherosclerosis
Current Vascular Pharmacology Therapeutic Potential of Endothelial Progenitor Cells in the Field of Orthopaedics
Current Stem Cell Research & Therapy Editorial (Thematic Issue: Uteroplacental Circulation and Fetal Vascular Development and Function)
Current Vascular Pharmacology